Free equity investment tool of Japanese companies

Credit Rating (Bankruptcy Risk): Institute of Applied Medicine (Annual ) Non-Consolidated

Financial Timeline

Financial Statement Risk Analysis: Institute of Applied Medicine (Annual ) (Non-Consolidated )

Special note

Cash(¥ 1 B) is more than the total liabilities(¥ 822 M). It is a very steady fiscal base!

[Date: 2010-09-30]  Danger : Warning : Caution : Good

Management Risk (*Sales is decrease )
Sales (¥ 2 B) is first term Sales (¥ 2 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ 270 M) is first term Net Income (¥ 431 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (11.15％) is first term Net Profit Margin (16.25％) less , there is a possibility that the profitability has deteriorated.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -255 M) & Financial Cash Flow (¥ -324 M) is a minus, Operating Cash Flow (¥ 475 M) is a plus,

Dividend
Under the situation of Net Income (¥ 270 M) & Operating Cash Flow (¥ 475 M) , Dividend (¥ -79 M) is paid.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -100 M) is Sales first term ratio (¥ -226 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2009-09-30]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -78 M) & Financial Cash Flow (¥ -122 M) is a minus, Operating Cash Flow (¥ 268 M) is a plus,

Dividend
Under the situation of Net Income (¥ 431 M) & Operating Cash Flow (¥ 268 M) , Dividend (¥ -85 M) is paid.